Aptamer AS۱۴۱۱-functionalized gold nanoparticle-melittin complex for targeting MCF-۷ breast cancer cell line

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 153

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_NAMJ-9-2_007

تاریخ نمایه سازی: 15 فروردین 1401

چکیده مقاله:

Objective(s): Several studies reported the apoptotic and lytic activity of melittin (Mel) in different tumor cells. In this study, a novel nano-complex was developed composed of AS۱۴۱۱aptamers, melittin and gold nanoparticle for the treatment of breast cancer cells. Materials and Methods: Gold nanoparticles (GNP) were synthesized using reduction of tetrachloroauric acid (HAuCl۴). Melittin modified with cysteine and AS۱۴۱۱aptamer conjugated to the gold nanoparticle. Gel retardation assay was used to prove the formation of GNP-Mel-AS۱۴۱۱ complex. Physicochemical properties of complex were investigated by Dynamic Light Scattering (DLS). The cytotoxicity of Mel and GNP-Mel-AS۱۴۱۱ complex were evaluated in both MCF‐۷ (target) and L۹۲۹ (non-target) cells by the MTT assay. Results: The average size of GNP and GNP-Mel-AS۱۴۱۱ complex were ۲۰ ± ۲.۵ and ۲۷۰.۵± ۳.۲ respectively. The results of MTT assay revealed that this nanocomplex was more cytotoxic in MCF‐۷ (cell viability = ۱۹% ± ۲%) and less cytotoxic in L۹۲۹ cells (cell viability = ۷۳% ± ۱.۶%).Conclusion: The results of this study indicated that the gold nanoparticle-melittin-AS۱۴۱۱ complex had a potential value in cancer cell targeted delivery of melittin. 

نویسندگان

Payam Bayat

Immunology Research Center, BuAli Research Institute, Department of Immunology and Allergy, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Khalil Abnous

Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Soudabeh Balarastaghi

Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Seyed Mohamaad Taghdisi

Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Majid Saeedi

Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

Reavan Yazdian-Robati

Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Mahmoud Mahmoudi

Immunology Research Center, BuAli Research Institute, Department of Immunology and Allergy, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, ...
  • Tanaka T, Decuzzi P, Cristofanilli M, Sakamoto JH, Tasciotti E, ...
  • Shapiro CL, Recht A. Side effects of adjuvant treatment of ...
  • Samadian H, Hosseini-Nami S, Kamrava SK, Ghaznavi H, Shakeri-Zadeh A. ...
  • Jeong EH, Jung G, Hong CA, Lee H. Gold nanoparticle ...
  • Kim D-H, Seo J-M, Shin K-J, Yang S-G. Design and ...
  • Bates PJ, Reyes-Reyes EM, Malik MT, Murphy EM, O’toole MG, ...
  • Sader M, Courty J, Destouches D. Nanoparticles functionalized with ligands ...
  • Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ. ...
  • Girvan AC, Teng Y, Casson LK, Thomas SD, Jüliger S, ...
  • Pichiorri F, Palmieri D, De Luca L, Consiglio J, You ...
  • Van Den Bogaart G, Guzmán JV, Mika JT, Poolman B. ...
  • Zhou J, Wan C, Cheng J, Huang H, Lovell JF, ...
  • Turkevich J, Stevenson PC, Hillier J. A study of the ...
  • Shahdordizadeh M, Yazdian-Robati R, Ansari N, Ramezani M, Abnous K, ...
  • Dam DHM, Lee JH, Sisco PN, Co DT, Zhang M, ...
  • Abnous K, Danesh NM, Ramezani M, Lavaee P, Jalalian SH, ...
  • Bates PJ, Laber DA, Miller DM, Thomas SD, Trent JO. ...
  • Kong T, Zhou R, Zhang Y, Hao L, Cai X, ...
  • Rajabnejad SH, Mokhtarzadeh A, Abnous K, Taghdisi SM, Ramezani M, ...
  • Mansouri M, Moallem SA, Asili J, Etemad L. Cytotoxic and ...
  • Raghuraman H, Chattopadhyay A. Melittin: a membrane-active peptide with diverse ...
  • Yazdian-Robati R, Arab A, Ramezani M, Rafatpanah H, Bahreyni A, ...
  • Ramazi S, Zahiri J. Posttranslational modifications in proteins: resources, tools ...
  • Malik MT, O’Toole MG, Casson LK, Thomas SD, Bardi GT, ...
  • Zhang F, Correia A, Mäkilä E, Li W, Salonen J, ...
  • Misra SK, Ye M, Kim S, Pan D. Defined nanoscale ...
  • Russell PJ, Hewish D, Carter T, Sterling-Levis K, Ow K, ...
  • Van der Ven CF, Tibbitt MW, Conde J, Van Mil ...
  • Ajnai G, Chiu A, Kan T, Cheng C-C, Tsai T-H, ...
  • نمایش کامل مراجع